Full Press Release Details
Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic.
SGMT
Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
Key Takeaway: Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
Price reaction · baseline $3.79 (2023-12-01 close) · clean, no other SGMT news in the window
day 0 close
+7.1%
day 1 · peak
+9.5%
day 3
+6.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+110%
120-day peak, hindsight
Typical move
5.7%
average across 12 past catalysts
Cash runway
~69 mo
Minimal dilution risk
Lead asset
TVB-2640
Phase 2 · Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease